Mercer Global Advisors’s Lipocine LPCN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-9,359
| Closed | -$63K | – | 2004 |
|
|
2022
Q4 | $63K | Hold |
9,359
| – | – | ﹤0.01% | 1852 |
|
|
2022
Q3 | $72K | Sell |
9,359
-8,824
| -49% | -$67.9K | ﹤0.01% | 1747 |
|
|
2022
Q2 | $248K | Hold |
18,183
| – | – | ﹤0.01% | 1515 |
|
|
2022
Q1 | $423K | Sell |
18,183
-235
| -1% | -$5.47K | ﹤0.01% | 1315 |
|
|
2021
Q4 | $310K | Hold |
18,418
| – | – | ﹤0.01% | 1445 |
|
|
2021
Q3 | $341K | Buy |
18,418
+1,176
| +7% | +$21.8K | ﹤0.01% | 1368 |
|
|
2021
Q2 | $410K | Buy |
17,242
+4,818
| +39% | +$115K | ﹤0.01% | 1235 |
|
|
2021
Q1 | $319K | Sell |
12,424
-4,706
| -27% | -$121K | ﹤0.01% | 1281 |
|
|
2020
Q4 | $396K | Buy |
17,130
+2,941
| +21% | +$68K | ﹤0.01% | 960 |
|
|
2020
Q3 | $340K | Sell |
14,189
-1,812
| -11% | -$43.4K | 0.01% | 911 |
|
|
2020
Q2 | $343K | Buy |
16,001
+8,922
| +126% | +$191K | 0.01% | 804 |
|
|
2020
Q1 | $58K | Buy |
7,079
+2,941
| +71% | +$24.1K | ﹤0.01% | 1037 |
|
|
2019
Q4 | $27K | Sell |
4,138
-3,521
| -46% | -$23K | ﹤0.01% | 1160 |
|
|
2019
Q3 | $365K | Sell |
7,659
-2,353
| -24% | -$112K | 0.01% | 822 |
|
|
2019
Q2 | $332K | Sell |
10,012
-2,471
| -20% | -$81.9K | 0.01% | 836 |
|
|
2019
Q1 | $490K | Buy |
+12,483
| New | +$490K | 0.02% | 639 |
|